Drug intelligence / Profile preview

fuzhengkangai granule

Development stage
Unknown
Lead developer
Hubei Provincial Traditional Chinese Medical Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Fuzhengkangai granule is a Traditional Chinese Medicine (TCM) formulation developed by the Hubei Provincial Hospital of Chinese Medicine for the treatment of HIV infection and AIDS. Based on the TCM principle of 'Fuzheng' (strengthening the body's resistance), the granule is composed of several medicinal herbs, including *Astragalus membranaceus* and *Panax ginseng*, which are intended to modulate the immune system. The primary therapeutic goal is to increase or stabilize CD4+ T-lymphocyte counts and improve the quality of life for patients, often as an adjunct to highly active antiretroviral therapy (HAART). It is utilized within the Chinese medical system as a hospital preparation and has been the subject of various clinical trials evaluating its efficacy in immune reconstitution.

Other names
Fuzheng Kangai granuleFuzheng Kang'ai granule扶正抗艾颗粒
02

Targets

BCL-2 (BCL-2 family)PRKCA (Protein kinase C alpha)

Beyond the preview

Go deeper on fuzhengkangai granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fuzhengkangai granule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call